Wells Fargo & Company »

Arcutis Biotherapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $70k 22k 3.23
2023-09-30 $461k 87k 5.31
2023-06-30 $1.0M 107k 9.53
2022-12-31 $51k 3.4k 14.80
2022-09-30 $73k 3.9k 18.97
2022-06-30 $78k 3.7k 21.40
2022-03-31 $2.7M 139k 19.26
2021-12-31 $2.9M 142k 20.74
2021-09-30 $19M 773k 24.54
2021-06-30 $25M 898k 27.29
2021-03-31 $25M 877k 28.93
2020-12-31 $18M 644k 28.13
2020-09-30 $16M 556k 29.30
2020-06-30 $16M 527k 30.24
2020-03-31 $12M 414k 29.80